Clinical Trial

Study of the Drug B11-FC (Botulism Treatment)

Unknown Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated August 30, 2024 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Study of the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of the drug B11-FC with a single application in adults
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06580236
Lead Sponsor Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Conditions Botulism
Enrollment 40 participants
Start Date 2024-08
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-30